Literature DB >> 16699305

Severe reversible dilated cardiomyopathy in a patient with multiple endocrine neoplasia 2A syndrome.

A Gursoy1, M F Erdogan, N Kamel.   

Abstract

Pheochromocytoma may infrequently lead to dilated cardiomyopathy, which may reverse partially or completely after treatment. Progressive dyspnea, palpitations, and paroxysmal attacks of severe hypertension leading to cardiac failure had developed in a 25-yr-old woman. Chest radiography and echocardiography revealed a massive 4-chamber dilatation of the heart with an ejection fraction of 12%. Twenty-four-h urinary vanillylmandelic acid and metanephrine levels were elevated. Magnetic resonance imaging detected a large mass lesion in the right adrenal gland. Oral glucose tolerance testing revealed diabetes mellitus. Medical drug therapy with alpha-blocker, angiotensin converting enzyme inhibitor, beta-blocker, digoxin, and diuretic rapidly improved her cardiac condition. Repeat echocardiogram showed that the left ventricular function had improved substantially. The clinical condition of excess catecholaminemia (and thus, arterial hypertension and the abnormality of the glucose metabolism) subsided with complete resolution of the congestive heart failure following the surgical removal of the tumor. Evaluation for medullary thyroid carcinoma (MTC) revealed an elevated calcitonin level demonstrated by fine needle aspiration biopsy. There were no biochemical evidences for primary hyperparathyroidism. Multiple endocrine neoplasia 2 (MEN 2A) syndrome was diagnosed. An overwhelming secretion of catecholamine might cause severe cardiomyopathy and impair glucose metabolism, as evidenced by the improvement of both conditions following the medical treatment of catecholaminemia and surgical resection of the tumor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699305     DOI: 10.1007/BF03344110

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Reversible myocardial depression after massive catecholamine release from a pheochromocytoma.

Authors:  Z N Quezado; H R Keiser; M M Parker
Journal:  Crit Care Med       Date:  1992-04       Impact factor: 7.598

2.  Phaeochromocytoma and cardiomyopathy.

Authors:  I Scott; R Parkes; D P Cameron
Journal:  Med J Aust       Date:  1988-01-18       Impact factor: 7.738

3.  Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial two-dimensional echocardiographic observations.

Authors:  J B Lam; C Shub; S G Sheps
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

Review 4.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess.

Authors:  Jaime Kim; Sirimon Reutrakul; Dawn Belt Davis; Edwin L Kaplan; Samuel Refetoff
Journal:  Eur J Endocrinol       Date:  2004-12       Impact factor: 6.664

6.  Pheochromocytoma storm presenting as cardiovascular collapse at term pregnancy.

Authors:  Alexander Langerman; John A Schneider; R Parker Ward
Journal:  Rev Cardiovasc Med       Date:  2004       Impact factor: 2.930

7.  Phaeochromocytoma presenting as dilated cardiomyopathy.

Authors:  M N Attar; P K Moulik; G D Salem; E L Rose; A A Khaleeli
Journal:  Int J Clin Pract       Date:  2003 Jul-Aug       Impact factor: 2.503

8.  Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma.

Authors:  T D Wiesner; M Blüher; M Windgassen; R Paschke
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

Review 9.  Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy.

Authors:  A S Nanda; A Feldman; C S Liang
Journal:  Clin Cardiol       Date:  1995-07       Impact factor: 2.882

10.  Cardiomyopathy due to a pheochromocytoma. A reversible entity.

Authors:  K A Gatzoulis; G Tolis; A Theopistou; J H Gialafos; P K Toutouzas
Journal:  Acta Cardiol       Date:  1998       Impact factor: 1.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.